Skip to content

In-vivo multispectral optoacoustic imaging of thyroid nodules

In-vivo multispectral optoacoustic imaging of thyroid nodules - THYNODE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49819
Enrollment
30
Registered
2019-11-27
Start date
2020-09-18
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid nodules thyroid tumor

Interventions

Included patients will undergo MSOT imaging of the thyroid nodules.

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with thyroid nodules who underwent or will undergo an ultrasonography (with TIRADS score) with FNA if indicated and will be scheduled for a (hemi)thyroidectomy if indicated; 2. Age >= 18 years; 3. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Medical or psychiatric conditions that compromise the patients' ability to give informed consent; 2. Previous surgery in head and neck area on the ipsilateral side of the index nodule 3. Previous radiotherapy in head and neck area 4. Pregnancy

Design outcomes

Primary

MeasureTime frame
The main study endpoint is quantification of the optoacoustic signal (HbO2, HbR, HbT, sO2, fat, water and collagen) observed by multispectral optoacoustic imaging using the MSOT Acuity Echo in vivo in patients with thyroid nodules, also in relation to the definitive pathology results (benign vs malignant).

Secondary

MeasureTime frame
- To explore a potential correlation between endogenous optoacoustic signals in vivo with cytology (the standard-of-care of Bethesda scoring system derived from FNA) - To explore a potential correlation between endogenous optoacoustic signals in vivo with TIRADS ultrasonography scoring system (the scoring system used by radiologists when evaluating the thyroid nodules with ultrasonography).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)